The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

August 1, 2020

Conditions
Cardiovascular DiseasesCardiovascular AbnormalitiesHeart AttackStrokeHypertension
Interventions
DIETARY_SUPPLEMENT

CardioFlex Q10

CardioFlex Q10 is a cardiovascular health supplement developed to increase collagen production, repair connective tissues, and help the body metabolize fats and protein. CardioFlex Q10 contains high amounts of lysine, proline and vitamin C, which the body requires to produce connective tissue (collagen). CardioFlex Q10 also includes additional supporting nutrients such as vitamin E, selenium, bio flavonoids, Coenzyme Q10 (Ubiqionol) and magnesium. The ingredients in CardioFlex Q10 help regulate the body's production of cholesterol, strengthen the arteries and heart, and reverse oxidation.

DIETARY_SUPPLEMENT

Placebo

Isocaloric maltodextrin placebo that looks and tastes identical to CardioFLex Q10

Trial Locations (1)

R3T 6C5

Richardson Centre for Functional Foods and Nutraceuticals, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT03826914 - The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults | Biotech Hunter | Biotech Hunter